Skip to main content
. 2023 Oct 6;13:1242639. doi: 10.3389/fonc.2023.1242639

Table 3.

Primary and secondary outcomes in the TPCP cohort.

TPCP Cohort
n = 891
Follow-up Time (years)
 Median (IQR) 10.4 (8.2, 12.9)
Primary Outcome
 Metastatic Prostate Cancer 97
Secondary Outcomes
 Death from Prostate Cancer 56
 Death from Any Cause 301

IQR, Interquartile Range (25th – 75th percentile).